Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Sell
49
OFIX Quote, Financials, Valuation and Earnings
Last price:
$15.75
Seasonality move
:
6.64%
Day range:
$15.51 - $16.15
52-week range:
$10.24 - $20.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.76x
P/B ratio:
1.41x
Volume:
210.2K
Avg. volume:
193.6K
1-year change:
-7.88%
Market cap:
$624.9M
Revenue:
$799.5M
EPS (TTM):
-$3.04
Analysts' Opinion
-
Consensus RatingOrthofix Medical, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $22.80, Orthofix Medical, Inc. has an estimated upside of 44.49% from its current price of $15.78.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $18.00 representing 100% downside risk from its current price of $15.78.
Fair Value
-
According to the consensus of 4 analysts, Orthofix Medical, Inc. has 44.49% upside to fair value with a price target of $22.80 per share.
OFIX vs. S&P 500
-
Over the past 5 trading days, Orthofix Medical, Inc. has overperformed the S&P 500 by 4.69% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Orthofix Medical, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Orthofix Medical, Inc. has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Orthofix Medical, Inc. reported revenues of $205.6M.
Earnings Growth
-
Orthofix Medical, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Orthofix Medical, Inc. reported earnings per share of -$0.57.
Enterprise value:
763.4M
EV / Invested capital:
--
Price / LTM sales:
0.76x
EV / EBIT:
--
EV / Revenue:
0.93x
PEG ratio (5yr expected):
-0.36x
EV / Free cash flow:
-227.69x
Price / Operating cash flow:
1,166.63x
Enterprise value / EBITDA:
172.81x
Gross Profit (TTM):
$528.8M
Return On Assets:
-14%
Net Income Margin (TTM):
-14.56%
Return On Equity:
-24.94%
Return On Invested Capital:
-17.83%
Operating Margin:
-8.5%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $668.5M | $784.2M | $818.1M | $196.6M | $205.6M | |
| Gross Profit | $423.6M | $516.3M | $528.8M | $130.5M | $145.4M | |
| Operating Income | -$133.7M | -$85.6M | -$94.5M | -$16.8M | -$17.5M | |
| EBITDA | -$87.2M | -$27.6M | -$14.3M | -$1.7M | -$4.5M | |
| Diluted EPS | -$3.90 | -$3.14 | -$3.04 | -$0.71 | -$0.57 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $260.2M | $246.9M | $393.7M | $386.2M | $394.2M | |
| Total Assets | $500.4M | $449.7M | $905.7M | $867.9M | $832.6M | |
| Current Liabilities | $80M | $77.6M | $152.5M | $161.9M | $159.8M | |
| Total Liabilities | $135.6M | $116.1M | $290.2M | $341.9M | $390.1M | |
| Total Equity | $364.8M | $333.5M | $615.5M | $525.9M | $442.5M | |
| Total Debt | $24.3M | $25.5M | $106.6M | $152.2M | $201.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$37.4M | -$4.1M | $29.3M | $11.7M | $12.9M | |
| Cash From Investing | -$24.5M | -$41.5M | -$25.3M | -$6.2M | -$10.5M | |
| Cash From Financing | $41.7M | $44.1M | $27.3M | -$2.2M | -$5.4M | |
| Free Cash Flow | -$91M | -$45.1M | -$3.4M | $5.5M | $2.5M | |
OFIX
Sector
Market Cap
$624.9M
$28.3M
Price % of 52-Week High
77.05%
51.99%
Dividend Yield
0%
0%
Shareholder Yield
-2.71%
-1.59%
1-Year Price Total Return
-7.88%
-17.41%
Beta (5-Year)
0.788
0.495
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$15.58
200-day SMA
Buy
Level
$13.73
Bollinger Bands (100)
Buy
Level
14.52 - 15.7
Chaikin Money Flow
Buy
Level
17.5M
20-day SMA
Buy
Level
$15.51
Relative Strength Index (RSI14)
Buy
Level
54.56
ADX Line
Buy
Level
14.33
Williams %R
Neutral
Level
-37.6471
50-day SMA
Buy
Level
$15.43
MACD (12, 26)
Buy
Level
0.07
25-day Aroon Oscillator
Buy
Level
16
On Balance Volume
Neutral
Level
31.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.564)
Buy
CA Score
(Annual)
Level (-0.0191)
Buy
Beneish M-Score
(Annual)
Level (-3.3636)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (0.6658)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
Stock Forecast FAQ
In the current month, OFIX has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The OFIX average analyst price target in the past 3 months is $22.80.
-
Where Will Orthofix Medical, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Orthofix Medical, Inc. share price will rise to $22.80 per share over the next 12 months.
-
What Do Analysts Say About Orthofix Medical, Inc.?
Analysts are divided on their view about Orthofix Medical, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Orthofix Medical, Inc. is a Sell and believe this share price will drop from its current level to $18.00.
-
What Is Orthofix Medical, Inc.'s Price Target?
The price target for Orthofix Medical, Inc. over the next 1-year time period is forecast to be $22.80 according to 4 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is OFIX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Orthofix Medical, Inc. is a Buy. 3 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of OFIX?
You can purchase shares of Orthofix Medical, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Orthofix Medical, Inc. shares.
-
What Is The Orthofix Medical, Inc. Share Price Today?
Orthofix Medical, Inc. was last trading at $15.75 per share. This represents the most recent stock quote for Orthofix Medical, Inc.. Yesterday, Orthofix Medical, Inc. closed at $15.78 per share.
-
How To Buy Orthofix Medical, Inc. Stock Online?
In order to purchase Orthofix Medical, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get OFIX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OFIX
Sector
P/E ratio
--
24.24x
PEG ratio
-0.36x
-0.01x
P/B ratio
1.41x
1.84x
Price / LTM sales
0.76x
1.60x
Growth Metrics
OFIX
Sector
Revenue growth
4.59%
4.6%
Earnings growth
19.45%
10.71%
Revenue (5-year growth)
11.69%
6.45%
Earnings forecast
$0.44
-$0.19
Profitability
OFIX
Sector
Profitability FY 2024
$528.4M
$3.5M
Return on invested capital
-17.83%
-32.04%
Return on assets
-14%
-28.44%
Return on equity
-24.94%
-38.09%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
24
Estimated Next Earnings Date
Feb
3
Balance Sheet
OFIX
Sector
Total cash
$65.9M
$26.1M
Short term investments
--
$25.7M
Total assets
$893.3M
$76.4M
Long term debt
$201.3M
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
65
RGC alert for Jan 10
Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.
Sell
50
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
